Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands-based emerging growth company, filed this Form 8-K on May 19, 2026. The filing addresses a compliance issue regarding the timely submission of periodic financial reports to the U.S. Securities and Exchange Commission (SEC).
Key Financial Metrics
This filing is a Current Report regarding listing compliance and does not contain financial statements. Consequently, the document provides no data on revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes
The material event reported is the receipt of a notice from The Nasdaq Stock Market LLC on May 19, 2026. The Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it failed to file its Quarterly Report on Form 10-Q for the period ended March 31, 2026, by the due date of May 15, 2026.
Outlook, Risks, and Management Commentary
- Delisting Risk: While the notice has no immediate effect on trading, failure to regain compliance will result in the delisting of the Company's securities from Nasdaq.
- Compliance Timeline: The Company has 60 calendar days from the notice date to file the missing report or submit a compliance plan. If a plan is accepted, the Company may receive up to 180 calendar days from the original due date to regain compliance.
- Management Action: Management states it is working diligently to complete and file the Quarterly Report and expects to regain compliance, though no specific timing assurances are provided.
- Forward-Looking Statements: The filing includes standard disclaimers that future expectations are subject to significant risks and uncertainties.
Investor Verification Checklist
- Verify the current status of the Form 10-Q for the quarter ended March 31, 2026, on the SEC EDGAR database.
- Monitor Nasdaq announcements for any updates regarding the Company's compliance plan or potential delisting proceedings.
- Review the attached Press Release (Exhibit 99.1) for any additional details on the delay.
- Assess the impact of the listing deficiency on the liquidity and trading status of Ordinary Shares (AFJK), Rights (AFJKR), and Units (AFJKU).